NanoViricides
NNVC
#10132
Rank
ยฃ16.61 M
Marketcap
ยฃ0.92
Share price
0.82%
Change (1 day)
-19.31%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : ยฃ0.98 Million

According to NanoViricides's latest financial reports the company's total liabilities are ยฃ0.98 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30ยฃ1.07 M-32.87%
2023-06-30ยฃ1.6 M371.38%
2022-06-30ยฃ0.33 M33.7%
2021-06-30ยฃ0.25 M-85.41%
2020-06-30ยฃ1.74 M-22.42%
2019-06-30ยฃ2.24 M236.03%
2018-06-30ยฃ0.66 M-87%
2017-06-30ยฃ5.13 M-49.61%
2016-06-30ยฃ10.19 M28.93%
2015-06-30ยฃ7.9 M-33.99%
2014-06-30ยฃ11.97 M116.83%
2013-06-30ยฃ5.52 M386.92%
2012-06-30ยฃ1.13 M210.02%
2011-06-30ยฃ0.36 M-77.57%
2010-06-30ยฃ1.63 M421.15%
2009-06-30ยฃ0.31 M-39.2%
2008-06-30ยฃ0.51 M21.25%
2007-06-30ยฃ0.42 M-47.95%
2006-06-30ยฃ0.81 M2085.81%
2005-06-30ยฃ0.03 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioCryst Pharmaceuticals
BCRX
ยฃ0.62 B 63,757.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ1.00 B 102,199.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ27.83 B 2,837,744.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.76 B 5,992,077.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.27 B 5,942,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ46.00 B 4,690,559.16%๐Ÿ‡ฌ๐Ÿ‡ง UK